NOS2 and Hepatic fibrosis: Therefore, the inhibitory effect of ETME on NO production via the inhibition of LPS-induced iNOS expression in ImKCs suggests that ETME may be a therapeutic candidate for oxidative stress and inflammatory diseases in the liver, including liver fibrosis.